Th17 Cells and IL-17 As Novel Immune Targets in Ovarian Cancer Therapy

Figure 1

Flow cytometric analysis of Th17 cells in the peripheral blood (a) and tumor (b) of serous ovarian cancer patient.

(a)

(b)